Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.

Fractionated radiosurgery will be delivered to atypical meningioma lesions in salvage setting for patients who present post-surgical residual lesion or develop recurrence.

  • 0 views
  • 24 Oct, 2021
  • 1 location
An Open-Label, Phase 2 Study of NEO100 in Participants With Residual, Progressive or Recurrent High-Grade Meningioma

patients with residual high-grade meningioma following resection surgery, radiographically-confirmed progression of high-grade meningioma or recurrent high-grade meningioma. There will be up to 30 patients

  • 0 views
  • 13 Oct, 2022
  • 1 location
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed

x-rays
ct scan
central pathology review
step 2
tumor cells
  • 1040 views
  • 07 Oct, 2022
  • 122 locations
Therapeutic Endovascular Embolization for Intracranial Meningioma (e-men)

The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but

  • 0 views
  • 22 Oct, 2022
  • 1 location
Apatinib in the Treatment of Recurrent Atypical/Malignant Meningioma in Adults

Apatinib mesylate may be an effective treatment for recurrent atypical/malignant meningioma. This prospective clinical study is now planned to verify the effectiveness and safety of apatinib

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location
Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma Intracranial Hemangiopericytoma or Intracranial Hemangioblastoma

works in treating patients with recurrent or unresectable meningioma, intracranial hemangiopericytoma, or intracranial hemangioblastoma.

  • 89 views
  • 07 Nov, 2020
  • 2 locations
Cabozantinib for Patients With Recurrent or Progressive Meningioma

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

measurable disease
platelet count
karnofsky performance status
neutrophil count
hysterectomy
  • 0 views
  • 08 Jul, 2022
  • 1 location
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma

This research study is studying a drug as a possible treatment for High Grade Meningioma.

tumor cells
dexamethasone
recurrent meningioma
  • 1 views
  • 19 Aug, 2021
  • 1 location
Intravenous Tranexamic Acid Reducing Intraoperative Blood Loss in Huge Meningiomas Resection

Intra-operative blood loss of huge meningioma resection patients on average was over 1000ml. Intra-operative massive hemorrhage was associated with longer hospital of stay, higher expense, and

tranexamic acid
  • 0 views
  • 07 Oct, 2022
  • 1 location
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Meningiomas are known to be the most frequent intracranial neoplasms and account for approx. 25-33% of all intracranial tumours.Targeted radionuclide therapy with radiolabelled somatostatin

ct scan
karnofsky performance status
peptide receptor radionuclide therapy
dotatoc
somatostatin
  • 0 views
  • 07 Oct, 2022
  • 1 location